Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing
September 16, 2022 at 11:35 AM EDT
A Villanova-based biotech startup focus on heart disease gets a new CEO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.